Published in Am J Gastroenterol on December 01, 2000
Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. Int J Med Sci (2006) 1.33
Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev (2012) 1.30
Naturally occurring mutations in large surface genes related to occult infection of hepatitis B virus genotype C. PLoS One (2013) 1.11
Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci (2010) 1.06
Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection. Saudi J Gastroenterol (2009) 1.03
Association between syphilis, antibodies to herpes simplex virus type 2, and recreational drug use and hepatitis B virus infection in the Women's Interagency HIV Study. Clin Infect Dis (2004) 0.92
Dual chronic hepatitis B virus and hepatitis C virus infection. Hepatol Int (2009) 0.85
Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy. Virol J (2010) 0.84
Risk of hepatitis B infections in Olympic wrestling. Br J Sports Med (2007) 0.83
Prevalence of occult hepatitis B virus in plasma and peripheral blood mononuclear cell compartments of patients with chronic hepatitis C infection in tehran-iran. Hepat Mon (2013) 0.80
Incidence of transaminitis among HIV-infected patients with occult hepatitis B. J Clin Virol (2008) 0.80
Role of occult hepatitis B virus infection in chronic hepatitis C. World J Gastroenterol (2015) 0.79
Association of preS/S Mutations with Occult Hepatitis B Virus (HBV) Infection in South Korea: Transmission Potential of Distinct Occult HBV Variants. Int J Mol Sci (2015) 0.79
The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management. Ann Gastroenterol (2015) 0.79
Predictors and noninvasive identification of severe liver fibrosis in patients with chronic hepatitis C. Dig Dis Sci (2007) 0.78
The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China. PLoS One (2014) 0.76
Genetic variation of occult hepatitis B virus infection. World J Gastroenterol (2016) 0.75
Serum transaminase values in HIV-infected patients with previous HBV infection, with and without HCV antibodies. Am J Gastroenterol (2001) 0.75
Evolution of liver transplantation. Hepatology (1982) 19.54
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology (1994) 3.15
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology (1997) 3.10
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
Liver transplantation in adults. Hepatology (1982) 2.89
Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62
Hypothalamic-pituitary-gonadal dysfunction in men using cimetidine. N Engl J Med (1979) 2.61
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32
Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med (1993) 2.29
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis (2002) 2.24
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol (1988) 2.21
Acute liver failure. Lancet (1995) 2.09
Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet (1986) 2.07
Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology (1981) 2.07
The use of interferon for the treatment of viral hepatitis in pediatric liver transplant recipients. J Okla State Med Assoc (1995) 2.02
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
Biliary Excretion of Cyclosporine in Liver Transplant Patients. Transplant Proc (1985) 1.98
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (1999) 1.98
Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc (2000) 1.97
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Liver transplantation: an overview. Hepatology (1988) 1.86
Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses. Am J Gastroenterol (2005) 1.85
Gastrointestinal manifestations of Behcet's disease. J Clin Gastroenterol (2000) 1.81
Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc (1993) 1.78
Heatstroke: its clinical and pathological presentation, with particular attention to the liver. Am J Gastroenterol (1992) 1.76
Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts. Transplantation (1985) 1.75
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci (2000) 1.71
In vivo hepatic volume determination using sonography and computed tomography. Validation and a comparison of the two techniques. Gastroenterology (1985) 1.71
Single oral dose metronidazole therapy for Gardnerella vaginalis vaginitis in adolescent females. J Adolesc Health Care (1983) 1.70
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol (2005) 1.64
Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2. Gastroenterology (1990) 1.63
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study. Dig Liver Dis (2000) 1.62
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Early versus late surgery for ileo-caecal Crohn's disease. Aliment Pharmacol Ther (2007) 1.60
Blood ethanol levels in sober alcohol users seen in an emergency room. Life Sci (1981) 1.58
Liver transplantation for fulminant hepatic failure. Semin Liver Dis (1985) 1.56
Use of external shock-wave lithotripsy and adjuvant ursodiol for treatment of radiolucent gallstones. A national multicenter study. Dig Dis Sci (1989) 1.56
Transjugular renal biopsy in patients with liver disease. Am J Kidney Dis (2001) 1.56
Angiography of liver transplantation patients. Radiology (1985) 1.53
Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology (1987) 1.53
Acute and chronic renal failure in liver transplantation. Nephron (1990) 1.52
Medical aspects of liver transplantation. Hepatology (1984) 1.52
Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52
Sex hormone-related functions in regenerating male rat liver. Gastroenterology (1986) 1.51
Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatology (1992) 1.50
Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut (2004) 1.50
Estrogen and androgen receptors in liver: their role in liver disease and regeneration. Semin Liver Dis (1985) 1.50
A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut (2000) 1.48
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. Aliment Pharmacol Ther (2006) 1.48
Estrogen-binding proteins of male rat liver: influences of hormonal changes. Arch Biochem Biophys (1980) 1.48
Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig Liver Dis (2001) 1.46
Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. Dig Liver Dis (2004) 1.46
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45
Gastrointestinal tract hemorrhage. The value of a nasogastric aspirate. Arch Intern Med (1990) 1.44
Use of bovine lactoferrin for Helicobacter pylori eradication. Dig Liver Dis (2003) 1.44
Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res (1987) 1.43
Gonadal dysfunction and inadequate sexual performance in alcoholic cirrhotic men. Gastroenterology (1988) 1.43
Hypogonadism in alcoholic liver disease: evidence for a double defect. Gastroenterology (1974) 1.43
Ageing affects anoxia/reoxygenation injury in rat hepatocytes. Scand J Gastroenterol (1998) 1.42
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly. Eur J Gastroenterol Hepatol (1997) 1.42
Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b. Am Fam Physician (1996) 1.41
Mesenchymal tumors of the liver. Clin Liver Dis (2001) 1.40
Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study). Dig Liver Dis (2000) 1.39
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology (1998) 1.39
Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis. Cancer (1991) 1.39
Helicobacter pylori infection and growth delay in older children. Arch Dis Child (1997) 1.39
Response to criticisms of the US FDA parametric approach for withdrawal time estimation: rebuttal and comparison to the nonparametric method proposed by Concordet and Toutain. J Vet Pharmacol Ther (2000) 1.38
The long term outcome of gastric non-invasive neoplasia. Gut (2003) 1.37
Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis. Aliment Pharmacol Ther (2008) 1.36
Heartburn of pregnancy. Gastroenterology (1977) 1.32
Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma. J Pediatr (1985) 1.32
Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Hum Immunol (1988) 1.31
Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer (1999) 1.31
Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology (1986) 1.31
Diagnostic and interventional radiology in liver transplantation. Gastroenterol Clin North Am (1988) 1.31
Effect of pregnancy on gastrointestinal transit. Dig Dis Sci (1982) 1.29
Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology (1999) 1.29
Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology (1986) 1.27
Analysis of liver transplantation. Hepatology (1984) 1.26
Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol (2000) 1.24
Role of bile and bile salts on cyclosporine absorption in dogs. Transplant Proc (1987) 1.24
Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med (1996) 1.24
The quality of life following liver transplantation: a preliminary report. Gastroenterol Clin North Am (1988) 1.23
Effectiveness of smoking cessation interventions integrated into primary care practice. Med Care (1988) 1.23
Nutritional status and lung function in patients with emphysema and chronic bronchitis. Chest (1983) 1.23
Effects of renal impairment on liver transplantation. Gastroenterology (1987) 1.23